IL6R and pancreatic neoplasm: While the response to cytokines may vary between cell lines that may lack expression of their cognate receptors, the ubiquitous expression of gp130 in most pancreatic cancer cells allows for a response to a complex formed by IL-6 fused to its soluble receptor sIL-6R (IL-6-sIL-6R).